{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T07:22:46Z","timestamp":1795245766057,"version":"4.10.3"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Persistent cervical infections with carcinogenic human papillomaviruses (HPV) cause virtually all cervical cancer. Cytologic abnormalities are the manifestations of HPV infections used to identify women at risk. To compare the potential of the full range of anogenital HPV genotypes to induce cytopathic effects, we examined the influences of HPV type, viral load, and age on cytopathology among 1,222 women having a single HPV type at enrollment into a 10,000-woman population-based study in Costa Rica. Cervical specimens were tested for \u223c40 HPV types by MY09\/MY11 L1 primer PCR and type-specific dot blot hybridization. Types were organized by phylogenetic species and cancer risk. PCR signal strength served as a qualitative surrogate for viral load. Overall, 24.8% [95% confidence interval (95% CI), 22.4-27.3] of single prevalent HPV infections had concurrent abnormalities (atypical squamous cells or worse) ranging from 0.0% to 80.0% based on HPV type. Noncarcinogenic \u03b13\/\u03b115 types, although highly prevalent, uncommonly caused cytologic abnormalities (13.1%; 95% CI, 9.8-17.0). In contrast, one quarter to nearly one half of infections with a single major carcinogenic species type (\u03b19\/\u03b111\/\u03b17\/\u03b15\/\u03b16) produced abnormalities. Greater abnormalities were observed with increasing qualitative viral load of carcinogenic types; fewer abnormalities were observed among older women (&amp;gt;54 years). A high percentage (46.2%) of detected abnormalities in women infected with HPV16 or related \u03b19 types were high grade or worse, consistent with strong carcinogenicity, compared with 10.7% in women infected with \u03b17 types, including HPV18, a major cause of adenocarcinoma. The lack of evident severe abnormalities associated with HPV18 and related HPV types might have implications for screening for poorly detected glandular and \u03b17-related lesions. (Cancer Res 2006; 66(20): 10112-9)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-1812","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T09:42:10Z","timestamp":1161164530000},"page":"10112-10119","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Relationships of Human Papillomavirus Type, Qualitative Viral Load, and Age with Cytologic Abnormality"],"prefix":"10.1158","volume":"66","author":[{"given":"Melinda Butsch","family":"Kovacic","sequence":"first","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"},{"name":"2Cancer Prevention Fellowship Program, National Cancer Institute, NIH, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[{"name":"3Proyecto Epidemiolo\u0301gico Guanacaste;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholom","family":"Wacholder","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"},{"name":"3Proyecto Epidemiolo\u0301gico Guanacaste;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"Hutchinson","sequence":"additional","affiliation":[{"name":"5Women and Infants' Hospital, Providence, Rhode Island; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Concepcio\u0301n","family":"Bratti","sequence":"additional","affiliation":[{"name":"3Proyecto Epidemiolo\u0301gico Guanacaste;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Morales","sequence":"additional","affiliation":[{"name":"3Proyecto Epidemiolo\u0301gico Guanacaste;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Alfaro","sequence":"additional","affiliation":[{"name":"4Laboratorio Nacional de Citologi\u0301a, Caja Costarricense de Seguro Social, San Jose, Costa Rica;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[{"name":"6Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"2022061622144175200_B1","doi-asserted-by":"crossref","unstructured":"Bosch FX, Manos MM, Munoz N, et al. Prevalence of HPV DNA in cervical cancer: a worldwide perspective. J Natl Cancer Inst\u20081995; 87: 796\u2013802.","DOI":"10.1093\/jnci\/87.11.796"},{"key":"2022061622144175200_B2","doi-asserted-by":"crossref","unstructured":"Munoz N, Bosch FX, De Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med\u20082003; 348: 518\u201327.","DOI":"10.1056\/NEJMoa021641"},{"key":"2022061622144175200_B3","doi-asserted-by":"crossref","unstructured":"Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol\u20081999; 189: 12\u20139.","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"2022061622144175200_B4","doi-asserted-by":"crossref","unstructured":"Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA\u20082002; 287: 2114\u20139.","DOI":"10.1001\/jama.287.16.2114"},{"key":"2022061622144175200_B5","doi-asserted-by":"crossref","unstructured":"Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol\u20081995; 172: 946\u201354.","DOI":"10.1016\/0002-9378(95)90026-8"},{"key":"2022061622144175200_B6","doi-asserted-by":"crossref","unstructured":"Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Res Virol\u20081994; 145: 83\u201392.","DOI":"10.1038\/bjc.1994.28"},{"key":"2022061622144175200_B7","doi-asserted-by":"crossref","unstructured":"Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer\u20082003; 106: 396\u2013403.","DOI":"10.1002\/ijc.11222"},{"key":"2022061622144175200_B8","doi-asserted-by":"crossref","unstructured":"Hall S, Lorincz A, Shah F, et al. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol\u20081996; 62: 353\u20139.","DOI":"10.1006\/gyno.1996.0248"},{"key":"2022061622144175200_B9","doi-asserted-by":"crossref","unstructured":"Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet\u20082002; 360: 228\u20139.","DOI":"10.1016\/S0140-6736(02)09463-1"},{"key":"2022061622144175200_B10","doi-asserted-by":"crossref","unstructured":"Schneider A, Zahm DM, Greinke C, Kirchmayr R, Nindl I. Different detectability of high-risk HPV in smears from incident and prevalent high-grade squamous intraepithelial lesions of the cervix. Gynecol Oncol\u20081997; 65: 399\u2013404.","DOI":"10.1006\/gyno.1997.4693"},{"key":"2022061622144175200_B11","doi-asserted-by":"crossref","unstructured":"Sun CA, Liu JF, Wu DM, et al. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet\u20082002; 76: 41\u20137.","DOI":"10.1016\/S0020-7292(01)00529-X"},{"key":"2022061622144175200_B12","doi-asserted-by":"crossref","unstructured":"Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol\u20081995; 173: 1432\u20137.","DOI":"10.1016\/0002-9378(95)90629-0"},{"key":"2022061622144175200_B13","doi-asserted-by":"crossref","unstructured":"Castle PE, Schiffman M, Wheeler CM. Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer. Am J Obstet Gynecol\u20082004; 191: 1590\u20137.","DOI":"10.1016\/j.ajog.2004.05.018"},{"key":"2022061622144175200_B14","doi-asserted-by":"crossref","unstructured":"Jacobs MV, Walboomers J, Snijders P, et al. Distribution of 37 HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer\u20082000; 87: 221\u20137.","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2"},{"key":"2022061622144175200_B15","doi-asserted-by":"crossref","unstructured":"Sherman ME, Schiffman M, Cox JT. Effects of age and HPV viral load on colposcopy triage: data from the randomized atypical squamous cells of undetermined significance\/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst\u20082002; 94: 102\u20137.","DOI":"10.1093\/jnci\/94.2.102"},{"key":"2022061622144175200_B16","doi-asserted-by":"crossref","unstructured":"Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis\u20082005; 191: 1808\u201316.","DOI":"10.1086\/428779"},{"key":"2022061622144175200_B17","doi-asserted-by":"crossref","unstructured":"Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst\u20082000; 92: 464\u201374.","DOI":"10.1093\/jnci\/92.6.464"},{"key":"2022061622144175200_B18","doi-asserted-by":"crossref","unstructured":"Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis\u20082005; 191: 1796\u2013807.","DOI":"10.1086\/428850"},{"key":"2022061622144175200_B19","doi-asserted-by":"crossref","unstructured":"Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer\u20082001; 91: 412\u201320.","DOI":"10.1002\/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M"},{"key":"2022061622144175200_B20","doi-asserted-by":"crossref","unstructured":"Pham TH, Nguyen TH, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer\u20082003; 104: 213\u201320.","DOI":"10.1002\/ijc.10936"},{"key":"2022061622144175200_B21","doi-asserted-by":"crossref","unstructured":"Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer\u20082003; 103: 413\u201321.","DOI":"10.1002\/ijc.10825"},{"key":"2022061622144175200_B22","doi-asserted-by":"crossref","unstructured":"Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica\u20081997; 1: 362\u201375.","DOI":"10.1590\/S1020-49891997000500005"},{"key":"2022061622144175200_B23","doi-asserted-by":"crossref","unstructured":"Bratti MC, Rodriguez AC, Schiffman M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica\u20082004; 15: 75\u201389.","DOI":"10.1590\/S1020-49892004000200002"},{"key":"2022061622144175200_B24","doi-asserted-by":"crossref","unstructured":"Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09\/11 PCR methods. J Med Virol\u20082002; 68: 417\u201323.","DOI":"10.1002\/jmv.10220"},{"key":"2022061622144175200_B25","doi-asserted-by":"crossref","unstructured":"Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09\/MY11 and GP5+\/GP6+ primer systems. J Clin Microbiol\u20081997; 35: 1304\u201310.","DOI":"10.1128\/jcm.35.6.1304-1310.1997"},{"key":"2022061622144175200_B26","doi-asserted-by":"crossref","unstructured":"Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol\u20082005; 6: 204.","DOI":"10.1016\/S1470-2045(05)70086-3"},{"key":"2022061622144175200_B27","doi-asserted-by":"crossref","unstructured":"Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology\u20082005; 337: 76\u201384.","DOI":"10.1016\/j.virol.2005.04.002"},{"key":"2022061622144175200_B28","doi-asserted-by":"crossref","unstructured":"Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis\u20081996; 174: 679\u201389.","DOI":"10.1093\/infdis\/174.4.679"},{"key":"2022061622144175200_B29","doi-asserted-by":"crossref","unstructured":"Shah KV, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J Clin Microbiol\u20081997; 35: 517\u20139.","DOI":"10.1128\/jcm.35.2.517-519.1997"},{"key":"2022061622144175200_B30","doi-asserted-by":"crossref","unstructured":"Peyton CL, Schiffman M, Lorincz AT, et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol\u20081998; 36: 3248\u201354.","DOI":"10.1128\/JCM.36.11.3248-3254.1998"},{"key":"2022061622144175200_B31","unstructured":"Gravitt PE, Burk RD, Lorincz A, et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev\u20082003; 12: 477\u201384."},{"key":"2022061622144175200_B32","doi-asserted-by":"crossref","unstructured":"Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA\u20082000; 283: 87\u201393.","DOI":"10.1001\/jama.283.1.87"},{"key":"2022061622144175200_B33","doi-asserted-by":"crossref","unstructured":"Castle PE, Schiffman M, Bratti MC, et al. A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis\u20082004; 190: 458\u201367.","DOI":"10.1086\/421916"},{"key":"2022061622144175200_B34","doi-asserted-by":"crossref","unstructured":"Castle PE, Jeronimo J, Schiffman M, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res\u20082006; 66: 1218\u201324.","DOI":"10.1158\/0008-5472.CAN-05-3066"},{"key":"2022061622144175200_B35","doi-asserted-by":"crossref","unstructured":"Castle PE, Schiffman M, Scott DR, et al. Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiol Biomarkers Prev\u20082005; 14: 1311\u20134.","DOI":"10.1158\/1055-9965.EPI-04-0799"},{"key":"2022061622144175200_B36","doi-asserted-by":"crossref","unstructured":"Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Pretet JL. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol\u20082006; 35: 270\u20137.","DOI":"10.1016\/j.jcv.2005.09.001"},{"key":"2022061622144175200_B37","doi-asserted-by":"crossref","unstructured":"Schlecht NF, Trevisan A, Duarte-Franco E, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer\u20082003; 103: 519\u201324.","DOI":"10.1002\/ijc.10846"},{"key":"2022061622144175200_B38","doi-asserted-by":"crossref","unstructured":"van Duin M, Snijders PJ, Schrijnemakers HF, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II\/III and viral clearance. Int J Cancer\u20082002; 98: 590\u20135.","DOI":"10.1002\/ijc.10232"},{"key":"2022061622144175200_B39","doi-asserted-by":"crossref","unstructured":"Ylitalo N, Sorensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet\u20082000; 355: 2194\u20138.","DOI":"10.1016\/S0140-6736(00)02402-8"},{"key":"2022061622144175200_B40","doi-asserted-by":"crossref","unstructured":"Abba MC, Mouron SA, Gomez MA, Dulout FN, Golijow CD. Association of human papillomavirus viral load with HPV16 and high-grade intraepithelial lesion. Int J Gynecol Cancer\u20082003; 13: 154\u20138.","DOI":"10.1136\/ijgc-00009577-200303000-00009"},{"key":"2022061622144175200_B41","doi-asserted-by":"crossref","unstructured":"Moberg M, Gustavsson I, Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer\u20082004; 112: 854\u20139.","DOI":"10.1002\/ijc.20480"},{"key":"2022061622144175200_B42","doi-asserted-by":"crossref","unstructured":"Moberg M, Gustavsson I, Wilander E, Gyllensten U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer\u20082005; 92: 891\u20134.","DOI":"10.1038\/sj.bjc.6602436"},{"key":"2022061622144175200_B43","doi-asserted-by":"crossref","unstructured":"Swan DC, Tucker RA, Tortolero-Luna G, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol\u20081999; 37: 1030\u20134.","DOI":"10.1128\/JCM.37.4.1030-1034.1999"},{"key":"2022061622144175200_B44","unstructured":"Sherman ME, Wang SS, Wheeler CM, et al. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev\u20082003; 12: 1038\u201344."},{"key":"2022061622144175200_B45","doi-asserted-by":"crossref","unstructured":"Clifford GM, Smith JS, Plummer M, Mun\u0303oz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer\u20082003; 88: 63\u201373.","DOI":"10.1038\/sj.bjc.6600688"},{"key":"2022061622144175200_B46","doi-asserted-by":"crossref","unstructured":"Kurman RJ, Schiffman MH, Lancaster WD, et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol\u20081988; 159: 293\u20136.","DOI":"10.1016\/S0002-9378(88)80070-X"},{"key":"2022061622144175200_B47","doi-asserted-by":"crossref","unstructured":"Woodman CB, Collins S, Rollason TP, et al. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet\u20082003; 361: 40\u20133.","DOI":"10.1016\/S0140-6736(03)12120-4"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/10112\/2555297\/10112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/10112\/2555297\/10112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:53:27Z","timestamp":1655427207000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/20\/10112\/526340\/Relationships-of-Human-Papillomavirus-Type"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":47,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,17]]},"published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-1812","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}